Skip to main content
Accelerating Clinical Trials in the EU
  • News article
  • 21 September 2023
  • European Medicines Agency
  • 1 min read

Multi-stakeholder platform: kick-off meeting report

Document icon in a blue background.

The establishment of a multi-stakeholder platform (MSP) enabling regular dialogue between regulators and clinical trials stakeholders is one of the priority actions of the Accelerating Clinical Trials in the European Union (ACT EU) multi-annual workplan 2022-2026.

In this context, a first multi-stakeholder workshop was held on 22 and 23 June 2023, to understand different stakeholder perspectives on how to improve the EU environment for clinical trials and agree on a model for the platform.

The summary report of the workshop is now available:

 

 

Details

Publication date
21 September 2023
Author
European Medicines Agency